TOVX - Theriva Biologics, Inc.
0.1808
-0.004 -1.991%
Share volume: 1,557,224
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.18
0.00
-0.02%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-12-2024 | 03-06-2025 | 05-14-2025 | 08-11-2025 | 11-12-2025 | |
| Assets | ||||||
| Total Assets | 40.108 M | 35.352 M | 32.161 M | 35.830 M | 30.836 M | |
| Current Assets | 19.533 M | 16.281 M | 12.476 M | 14.743 M | 9.903 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 1.832 M | 3.228 M | 1.587 M | 1.722 M | 1.721 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 16.409 M | 11.609 M | 10.014 M | 12.120 M | 7.528 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 314.000 K | 270.000 K | 253.000 K | 258.000 K | 249.000 K | |
| Other Assets | 20.261 M | 18.801 M | 19.432 M | 20.829 M | 20.684 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 40.108 M | 35.352 M | 32.161 M | 35.830 M | 30.836 M | |
| Total liabilities | 15.473 M | 16.285 M | 16.664 M | 25.207 M | 24.098 M | |
| Total current liabilities | 7.323 M | 7.585 M | 8.148 M | 12.394 M | 11.003 M | |
| Accounts Payable | 756.000 K | 859.000 K | 437.000 K | 607.000 K | 795.000 K | |
| Other liabilities | 6.788 M | 6.973 M | 5.685 M | 10.160 M | 10.793 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 98.000 K | 92.000 K | 1.504 M | 1.639 M | 1.654 M | |
| Other liabilities | 6.788 M | 6.973 M | 5.685 M | 10.160 M | 10.793 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 24.635 M | 19.067 M | 15.497 M | 10.623 M | 6.738 M | |
| Common stock | 355.336 M | 355.504 M | 355.604 M | 362.471 M | 362.977 M | |
| Retained earnings | -330.525 M | -334.971 M | -339.295 M | -352.353 M | -356.714 M |